1. Home
  2. SLMT vs CPIX Comparison

SLMT vs CPIX Comparison

Compare SLMT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brera Holdings PLC Class B Ordinary Shares

SLMT

Brera Holdings PLC Class B Ordinary Shares

HOLD

Current Price

$4.63

Market Cap

68.9M

Sector

N/A

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.75

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLMT
CPIX
Founded
2000
1999
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
73.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
SLMT
CPIX
Price
$4.63
$6.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.5K
68.4K
Earning Date
06-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$0.56
$1.85
52 Week High
$24.05
$6.61

Technical Indicators

Market Signals
Indicator
SLMT
CPIX
Relative Strength Index (RSI) 48.26 71.54
Support Level $4.28 $5.42
Resistance Level $6.89 N/A
Average True Range (ATR) 0.78 0.33
MACD -0.22 0.02
Stochastic Oscillator 14.23 100.00

Price Performance

Historical Comparison
SLMT
CPIX

About SLMT Brera Holdings PLC Class B Ordinary Shares

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: